Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Tuesday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Trading Up 2.1 %

Shares of Retractable Technologies stock opened at $0.60 on Tuesday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The stock has a market capitalization of $17.93 million, a P/E ratio of -1.11 and a beta of 2.06. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.34. The stock’s 50-day simple moving average is $0.74 and its 200 day simple moving average is $0.95.

Insider Buying and Selling

In related news, CEO Thomas J. Shaw acquired 71,422 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were acquired at an average price of $0.82 per share, with a total value of $58,566.04. Following the acquisition, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.49 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last ninety days, insiders acquired 179,649 shares of company stock valued at $143,163. Company insiders own 55.00% of the company’s stock.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.